Exponent Inc. (NASDAQ:EXPO) will be issuing its quarterly earnings data after the market closes on Wednesday, October 19th. Analysts expect the company to announce earnings of $0.34 per share for the quarter.
Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Tuesday, July 19th. The company reported $0.38 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by $0.05. The business earned $77.30 million during the quarter, compared to the consensus estimate of $80.46 million. Exponent had a return on equity of 16.02% and a net margin of 15.13%. On average, analysts expect Exponent to post $1.47 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.
Exponent Inc. (NASDAQ:EXPO) opened at 48.70 on Monday. The company has a market capitalization of $1.27 billion, a P/E ratio of 27.83 and a beta of 0.85. The company has a 50-day moving average of $50.08 and a 200 day moving average of $51.89. Exponent Inc. has a 12-month low of $44.82 and a 12-month high of $59.71.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 23rd. Investors of record on Friday, September 2nd were paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 1.48%. The ex-dividend date of this dividend was Wednesday, August 31st. Exponent’s payout ratio is currently 41.62%.
Several equities research analysts recently commented on the stock. Zacks Investment Research raised shares of Exponent from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 20th. Cantor Fitzgerald assumed coverage on shares of Exponent in a research note on Friday, August 26th. They set a “buy” rating and a $57.00 price objective on the stock. Finally, Avondale Partners assumed coverage on shares of Exponent in a research note on Thursday, July 7th. They set a “market perform” rating and a $60.00 price objective on the stock.
In other news, insider Paul Boehm sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, July 25th. The shares were sold at an average price of $51.42, for a total value of $257,100.00. Following the transaction, the insider now owns 29,045 shares in the company, valued at $1,493,493.90. The sale was disclosed in a legal filing with the SEC, which is available at this link. 3.50% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Fund Advisors increased its position in shares of Exponent by 2.4% in the second quarter. BlackRock Fund Advisors now owns 1,631,643 shares of the company’s stock valued at $95,304,000 after buying an additional 38,240 shares in the last quarter. Atlanta Capital Management Co. L L C increased its position in shares of Exponent by 4.4% in the second quarter. Atlanta Capital Management Co. L L C now owns 920,771 shares of the company’s stock valued at $53,782,000 after buying an additional 38,882 shares in the last quarter. State Street Corp increased its position in shares of Exponent by 0.8% in the second quarter. State Street Corp now owns 506,941 shares of the company’s stock valued at $29,612,000 after buying an additional 3,808 shares in the last quarter. Panagora Asset Management Inc. increased its position in shares of Exponent by 4.5% in the second quarter. Panagora Asset Management Inc. now owns 139,700 shares of the company’s stock valued at $8,160,000 after buying an additional 6,069 shares in the last quarter. Finally, BlackRock Investment Management LLC increased its position in shares of Exponent by 4.9% in the second quarter. BlackRock Investment Management LLC now owns 107,682 shares of the company’s stock valued at $6,290,000 after buying an additional 5,055 shares in the last quarter. Hedge funds and other institutional investors own 91.57% of the company’s stock.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.